Johnson & Johnson Sees $1.9M in Bullish Call Activity as Stock Hovers Near 52-Week Highs
By TrendSpider Editor
Johnson & Johnson is drawing attention in the options market Wednesday, with two unusual call contracts totaling $1,907,945 in combined premium hitting the tape as shares trade at $227.99, up a modest 0.09% on the session. Both contracts target the $230 strike, suggesting options traders are positio
Johnson & Johnson Sees $1.9M in Bullish Call Activity as Stock Hovers Near 52-Week Highs
Johnson & Johnson is drawing attention in the options market Wednesday, with two unusual call contracts totaling $1,907,945 in combined premium hitting the tape as shares trade at $227.99, up a modest 0.09% on the session. Both contracts target the $230 strike, suggesting options traders are positioning for a near-term move above current levels. With JNJ trading well above its 52-week low of $146.115 and within reach of its 52-week high of $251.705, the setup is drawing notable directional bets from the options market.
Key Drivers of the JNJ Stock Move
- Main Catalyst: Two unusual call contracts at the $230 strike were flagged today, one expiring May 15, 2026, with a size of 3,959 contracts and $1,405,445 in premium, and a second expiring June 18, 2026, with a size of 750 contracts and $502,500 in premium. Combined, the two contracts represent $1,907,945 in total premium.
- Bull Case: The May 15 contract came in at 120% of open interest, a strong signal of fresh, aggressive positioning rather than a hedge against an existing holding. With JNJ at $227.99, the $230 strike is only modestly out of the money, meaning these contracts do not require a dramatic move to reach profitability.
- Bear Case: Both contracts are currently out of the money, meaning JNJ needs to push through $230 before expiration to pay off. The May 15 expiration is just over two weeks away, leaving limited time for the position to work. If the stock stalls near current levels or pulls back, the $1,405,445 in near-term premium is at risk of expiring worthless.
The forward setup for JNJ looks constructive from a technical standpoint, with the stock consolidating in the upper half of its 52-week range between $146.115 and $251.705. The clustering of call activity at the $230 strike across two different expirations, May and June, suggests this is not a one-off speculative bet but a layered, directional view that JNJ is heading higher over the next several weeks. The June 18 contract gives traders a longer runway if the May catalyst does not materialize on schedule. Options activity of this nature, particularly when the near-term contract registers at 120% of open interest, often signals that institutional or informed participants are building a position ahead of an anticipated catalyst, whether that is a product update, pipeline news, or a broader healthcare sector rotation.
JNJ Unusual Options Activity
- Contract 1: Call | Strike: $230 | Expiry: May 15, 2026 | Volume: 3,959 | Open Interest: 120% (OTM) | Premium: $1,405,445
- Contract 2: Call | Strike: $230 | Expiry: June 18, 2026 | Volume: 750 | Open Interest: 12% (OTM) | Premium: $502,500
No put contracts were flagged in today's unusual activity scan, giving the options flow a distinctly one-sided, bullish character. The total unusual premium of $1,907,945 is concentrated entirely on the call side, with zero put contracts recorded.
JNJ Seasonality
Late April and May have historically been active periods for JNJ given the company's quarterly earnings cadence and healthcare conference season, which can create short-term volatility and directional moves that options traders look to capitalize on. The choice of a May 15 expiration suggests the buyer may be targeting a near-term event or technical breakout within the next 16 days.
JNJ Relative Performance
JNJ's 0.09% gain on the session is essentially flat, indicating the stock is not reacting to a specific headline catalyst today. The options activity appears to be anticipatory rather than reactive, with traders looking ahead rather than chasing a move that has already occurred. At $227.99, JNJ sits comfortably above the midpoint of its 52-week range, which spans from $146.115 to $251.705, reflecting relative strength within the large-cap healthcare space.